.svg){kind=icon}
Patient Engagement Suite
Technology informed by unparalleled Decentralized Trials (DCT) operational experience and delivered at global scale.
Fact Sheet
Advancing Respiratory Research: An Integrated Approach to Clinical Trials
How IQVIA delivers a holistic view of lung disease by combining patient-reported outcomes and objective data
May 01, 2026
Learn how IQVIA Patient Suite supports respiratory clinical trials by integrating eCOA, patient‑reported outcomes, and connected devices to capture both subjective symptoms and objective lung function data. This patient‑centric approach enables high‑quality, regulator‑ready evidence for asthma and COPD studies.
You may also be interested in
Fact Sheet
IQVIA Connected Devices: Ambulatory Blood Pressure Monitoring (ABPM)
24-Hour blood pressure assessment for clinical research
Fact Sheet
IQVIA Integrated COA Solutions: Licensing, Linguistic Validation, and eCOA Implementation
Empowering patient‑centered research through a modular, end‑to‑end COA solution
Related solutions
eCOA
Fast, flexible and proven, IQVIA’s industry-leading electronic clinical outcome assessment (eCOA) platform ramps up efficiencies, delivers real-time data, and sharpens insights through best-in-class technology and a better patient experience.
Connected Devices
Clinical trials face increasing pressure to deliver new treatments to market faster. IQVIA Connected Devices accelerates trial outcomes with medical device recommendations that fit your clinical study, deliver cleaner data, and speed data collection and analysis with lower patient and site burdens.